Inhibition of behab cleavage and primary central nervous system (CNS) tumors

Details for Australian Patent Application No. 2002318241 (hide)

Owner Yale University Hockfield, S. Matthews, R.

Inventors Hockfield, Susan; Matthews, Russell, T.

Agent Fisher Adams Kelly

Pub. Number AU-B-2002318241

PCT Number PCT/US02/22539

PCT Pub. Number WO2003/007880

Priority 60/306,046 17.07.01 US

Filing date 16 July 2002

Wipo publication date 3 March 2003

Acceptance publication date 1 May 2008

International Classifications

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 5/22 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Human cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

9 January 2003 Complete Application Filed

  Priority application(s): 60/306,046 17.07.01 US

22 May 2003 Application Open to Public Inspection

  Published as AU-B-2002318241

1 May 2008 Application Accepted

  Published as AU-B-2002318241

28 August 2008 Standard Patent Sealed

11 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002318242-VEGFR-1 ANTIBODIES TO TREAT BREAST CANCER

2002318240-APPARATUS AND METHOD OF CORRECTING BOW IN A HONEYCOMB EXTRUDATE